Ulster University spinout StimOxyGen has raised £1.5m to accelerate the development of its innovative therapy designed to overcome treatment resistance in solid tumours. The funding will also allow StimOxyGen to advance key preclinical studies, scale-up manufacturing, and expand its team as it moves towards clinical translation. By delivering oxygen directly to tumours, the MedTech’s lead … Continue reading Spinout raises £1.5m to tackle aggressive cancers